Alterations in a Panel of Serum Peptides Correlate with the Disease States of Multiple Myeloma

被引:0
|
作者
Bai, Ju [1 ]
He, Aili [1 ]
Zhang, Wanggang [1 ]
Yang, Yun [1 ]
Wang, Jianli [1 ]
Zhang, Pengyu [1 ]
Feng, Yuandong [1 ]
Zhang, Lei [2 ]
Chen, Hongli [1 ]
Wang, Xiaman [1 ]
Lei, Xiaoru [1 ]
Shen, Ying [1 ]
Huang, Lingjuan [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Hematol, Affiliated Hosp 2, Xian 710049, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Clin Lab, Affiliated Hosp 2, Xian 710049, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Dietary habits correlate with myeloma pathogenesis and treatment outcome in multiple myeloma
    Sester, Lilli
    Gambihler, Anna Katharina
    Kilian, Michael
    Friedrich, Mirco
    Frenking, Jan
    de Castilhos, Juliana
    John, Lukas
    Mai, Elias
    Platten, Michael
    Mueller-Tidow, Carsten
    Weinhold, Niels
    Goldschmidt, Hartmut
    Stein-Thoeringer, Christoph
    Raab, Marc
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S305 - S305
  • [22] SERUM RIBONUCLEASE IN MULTIPLE MYELOMA
    FINK, K
    ADAMS, WS
    SKOOG, WA
    AMERICAN JOURNAL OF MEDICINE, 1971, 50 (04): : 450 - +
  • [23] SERUM ALDOLASE IN MULTIPLE MYELOMA
    SACHS, BA
    ROSS, G
    CANCER, 1958, 11 (03) : 640 - 642
  • [24] SERUM C4A LEVELS IN MULTIPLE SCLEROSIS CORRELATE WITH DISEASE ACTIVITY
    Ingram, G.
    Morgan, B. P.
    Robertson, N. P.
    Hakobyan, S.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E54 - E54
  • [25] IgE levels correlate with survival in patients with multiple myeloma
    Nature Clinical Practice Oncology, 2008, 5 (1): : 6 - 7
  • [26] High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Shrivastava, Vikas
    Leitzel, Kim
    Christoulas, Dimitrios
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Anargyrou, Konstantinos
    Hamer, Peter
    Kastritis, Efstathios
    Carney, Walter
    Lipton, Allan
    LEUKEMIA RESEARCH, 2010, 34 (03) : 399 - 402
  • [27] Serum oncostatin M in multiple myeloma:: impact on disease severity and prognosis
    Koskela, K
    Pelliniemi, TT
    Rajamäki, A
    Pulkki, K
    Remes, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (01) : 52 - 56
  • [28] SERUM ZINC LEVELS IN PATIENTS WITH MULTIPLE-MYELOMA AND WALDENSTROMS DISEASE
    PUPPO, F
    CORSINI, G
    PANE, L
    VALENTE, T
    MANGINI, P
    DIBENEDETTO, G
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1983, 2 (02) : 167 - 172
  • [29] Serum YKL-40 isassociated with bone disease in multiple myeloma
    Mylin, A. K.
    Abildgaard, N.
    Johansen, J. S.
    Andersen, N. F.
    Gimsing, P.
    Knudsen, L. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 130 - 130
  • [30] Serum metabolomic alterations in multiple myeloma revealed by targeted and untargeted metabolomics approaches: a pilot study
    Chanukuppa, Venkatesh
    More, Tushar H.
    Taunk, Khushman
    Taware, Ravindra
    Chatterjee, I. Athagata
    Sharma, Sanjeevan
    Rapole, Srikanth
    RSC ADVANCES, 2019, 9 (51) : 29522 - 29532